Form 4: Hercules Capital Director Gayle Crowell Reports Acquisition of Shares

Sentiment:

SEC Form 4


Director Gayle Crowell reports acquiring 3,030 shares of Hercules Capital, Inc. stock at $19.80 per share due to re-election to the board.

Summary

  • Gayle Crowell, a director of Hercules Capital, Inc., reported acquiring 3,030 shares of common stock on June 20, 2024.
  • The shares were acquired at a price of $19.80 per share.
  • This acquisition was an automatic grant upon re-election to the board of directors, issued as restricted stock under the 2018 Non-Employee Director Plan.
  • The restricted stock vests in three equal installments annually from the grant date.
  • Following the transaction, Crowell beneficially owns 52,874 shares of Hercules Capital, Inc.
  • This total includes dividend reinvestment shares acquired on March 6, 2024 (1,068 shares) and May 21, 2024 (1,036 shares).

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares, even as part of a pre-determined plan, can be seen as a positive signal. However, it's a routine transaction.

Positives

  • Director's acquisition of shares signals confidence in the company.
  • Automatic grant upon re-election aligns director's interests with shareholders.

Future Outlook

The restricted stock vests in three equal installments annually from the grant date.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding director's holdings.
  • The acquisition of shares by a director can positively influence investor confidence.

Key Dates

DateDescription
March 6, 2024Acquisition of 1,068 dividend reinvestment shares.
May 21, 2024Acquisition of 1,036 dividend reinvestment shares.
June 20, 2024Acquisition of 3,030 shares of common stock as restricted stock upon re-election to the board.
June 24, 2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.